93 related articles for article (PubMed ID: 25771974)
1. Expression status of candidate genes in mesothelioma tissues and cell lines.
Melaiu O; Melissari E; Mutti L; Bracci E; De Santi C; Iofrida C; Di Russo M; Cristaudo A; Bonotti A; Cipollini M; Garritano SI; Foddis R; Lucchi M; Pellegrini S; Gemignani F; Landi S
Mutat Res; 2015 Jan; 771():6-12. PubMed ID: 25771974
[TBL] [Abstract][Full Text] [Related]
2.
Dell'Anno I; Barbarino M; Barone E; Giordano A; Luzzi L; Bottaro M; Migliore L; Agostini S; Melani A; Melaiu O; Catalano C; Cipollini M; Silvestri R; Corrado A; Gemignani F; Landi S
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32659970
[TBL] [Abstract][Full Text] [Related]
3. Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.
Servais EL; Colovos C; Rodriguez L; Bograd AJ; Nitadori J; Sima C; Rusch VW; Sadelain M; Adusumilli PS
Clin Cancer Res; 2012 May; 18(9):2478-89. PubMed ID: 22371455
[TBL] [Abstract][Full Text] [Related]
4. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma].
Wang YY; Zhang H; Bai H; Wang SH; Wu MN; An TT; Zhao J; Zhuo ML; Duan JC; Wang ZJ; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):162-8. PubMed ID: 23856136
[TBL] [Abstract][Full Text] [Related]
5. A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma.
Melaiu O; Cristaudo A; Melissari E; Di Russo M; Bonotti A; Bruno R; Foddis R; Gemignani F; Pellegrini S; Landi S
Mutat Res; 2012; 750(2):132-140. PubMed ID: 22198210
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients.
Bahnassy AA; Zekri AR; Abou-Bakr AA; El-Deftar MM; El-Bastawisy A; Sakr MA; El-Sherif GM; Gaafar RM
Exp Mol Pathol; 2012 Aug; 93(1):154-61. PubMed ID: 22504106
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.
Usami N; Fukui T; Kondo M; Taniguchi T; Yokoyama T; Mori S; Yokoi K; Horio Y; Shimokata K; Sekido Y; Hida T
Cancer Sci; 2006 May; 97(5):387-94. PubMed ID: 16630136
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation.
Burt BM; Bader A; Winter D; Rodig SJ; Bueno R; Sugarbaker DJ
Clin Cancer Res; 2012 Mar; 18(6):1568-77. PubMed ID: 22261806
[TBL] [Abstract][Full Text] [Related]
10. Kinesin family members KIF11 and KIF23 as potential therapeutic targets in malignant pleural mesothelioma.
Kato T; Lee D; Wu L; Patel P; Young AJ; Wada H; Hu HP; Ujiie H; Kaji M; Kano S; Matsuge S; Domen H; Kaga K; Matsui Y; Kanno H; Hatanaka Y; Hatanaka KC; Matsuno Y; de Perrot M; Yasufuku K
Int J Oncol; 2016 Aug; 49(2):448-56. PubMed ID: 27279560
[TBL] [Abstract][Full Text] [Related]
11. Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant pleural mesothelioma cell lines.
Kuramitsu Y; Miyamoto H; Tanaka T; Zhang X; Fujimoto M; Ueda K; Tanaka T; Hamano K; Nakamura K
Proteomics; 2009 Nov; 9(22):5078-89. PubMed ID: 19771552
[TBL] [Abstract][Full Text] [Related]
12. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.
Burt BM; Rodig SJ; Tilleman TR; Elbardissi AW; Bueno R; Sugarbaker DJ
Cancer; 2011 Nov; 117(22):5234-44. PubMed ID: 21523763
[TBL] [Abstract][Full Text] [Related]
13. CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma.
Aoe K; Amatya VJ; Fujimoto N; Ohnuma K; Hosono O; Hiraki A; Fujii M; Yamada T; Dang NH; Takeshima Y; Inai K; Kishimoto T; Morimoto C
Clin Cancer Res; 2012 Mar; 18(5):1447-56. PubMed ID: 22261805
[TBL] [Abstract][Full Text] [Related]
14. Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma.
Hirayama N; Tabata C; Tabata R; Maeda R; Yasumitsu A; Yamada S; Kuribayashi K; Fukuoka K; Nakano T
Respir Med; 2011 Jan; 105(1):137-42. PubMed ID: 21041073
[TBL] [Abstract][Full Text] [Related]
15. Computational genomic analysis of PARK7 interactome reveals high BBS1 gene expression as a prognostic factor favoring survival in malignant pleural mesothelioma.
Vavougios GD; Solenov EI; Hatzoglou C; Baturina GS; Katkova LE; Molyvdas PA; Gourgoulianis KI; Zarogiannis SG
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(7):L677-86. PubMed ID: 26254420
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
[TBL] [Abstract][Full Text] [Related]
17. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Gordon GJ; Mani M; Maulik G; Mukhopadhyay L; Yeap BY; Kindler HL; Salgia R; Sugarbaker DJ; Bueno R
Cancer Chemother Pharmacol; 2008 Apr; 61(4):549-58. PubMed ID: 17522864
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of in vitro cell motility and invasiveness of human malignant pleural mesothelioma cells through the HIF-1α-MUC1 pathway.
Goudarzi H; Iizasa H; Furuhashi M; Nakazawa S; Nakane R; Liang S; Hida Y; Yanagihara K; Kubo T; Nakagawa K; Kobayashi M; Irimura T; Hamada J
Cancer Lett; 2013 Oct; 339(1):82-92. PubMed ID: 23879962
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.
Ohta Y; Shridhar V; Kalemkerian GP; Bright RK; Watanabe Y; Pass HI
Cancer; 1999 Jun; 85(12):2570-6. PubMed ID: 10375104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]